WHAT IS MPS?

MPS disorders are a group of rare, genetic, inheritable, metabolic diseases, which form part of the lysosomal storage diseases (LSDs)14-17
  • They affect males and females equally (with the exception of MPS II, which mainly affects males) and can be as common as ~1 in 25,000 live births (with prevalence varying by region and ethnic background)16,18
  • MPS disorders are caused by a deficiency in enzymes responsible for degrading glycosaminoglycans (GAGs) [see table below]. As a result, GAGs accumulate in the lysosomes of many of the bodys cells, causing progressive damage throughout the body14-17
  • Multiple organs and systems can be involved, including the cardiovascular, skeletal, respiratory and neurologic systems16
  • Having an MPS disorder can lead to organ failure, cognitive impairment and reduced life expectancy16,17
To date, 11 different enzymatic deficiencies are known to cause seven MPS disorders:15-17 For more information about MPS, please visit www.MPSReference.com.
Sponsored and Funded by BioMarin International Ltd.
THE CONTENT AVAILABLE THROUGH THIS SITE IS FOR INFORMATIONAL AND EDUCATIONAL PURPOSES ONLY AND IS NOT A SUBSTITUTE FOR THE PROFESSIONAL JUDGMENT OF A HEALTHCARE PROFESSIONAL IN MANAGING PATIENTS. BIOMARIN DOES NOT GIVE MEDICAL ADVICE, NOR DOES IT PROVIDE MEDICAL OR DIAGNOSTIC SERVICES. YOUR RELIANCE UPON CONTENT OBTAINED BY YOU AT OR THROUGH THIS SITE IS SOLELY AT YOUR OWN RISK.
EU-MPS-00194 August 2022